Atea Pharmaceuticals (AVIR) Net Margin (2021)
Historic Net Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2021 value amounting to 60.95%.
- Atea Pharmaceuticals' Net Margin changed N/A to 60.95% in Q4 2021 from the same period last year, while for Sep 2022 it was 18.55%, marking a year-over-year increase of 30300.0%. This contributed to the annual value of 34.49% for FY2021, which is 570000.0% up from last year.
- According to the latest figures from Q4 2021, Atea Pharmaceuticals' Net Margin is 60.95%.
- In the past 5 years, Atea Pharmaceuticals' Net Margin ranged from a high of 60.95% in Q4 2021 and a low of 85.93% during Q3 2021